361 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Case Report
Pseudoprogression in lung cancer: a case report
Giulia Meoni ... Angela Stefania Ribecco
Published: October 30, 2020 Explor Target Antitumor Ther. 2020;1:372–380
This article belongs to the special issue Immunotherapy in Cancer Patients
Open Access
Original Article
Downregulation of 15-hydroxyprostaglandin dehydrogenase during acquired tamoxifen resistance and association with poor prognosis in ERα-positive breast cancer
Milene Volpato ... Valerie Speirs
Published: October 30, 2020 Explor Target Antitumor Ther. 2020;1:355–371
Open Access
Review
Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup ... Matthias G. J. Baud
Published: October 30, 2020 Explor Target Antitumor Ther. 2020;1:273–312
This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)
Open Access
Review
Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers
Giovanni Vicidomini ... Mario Santini
Published: October 30, 2020 Explor Target Antitumor Ther. 2020;1:343–354
This article belongs to the special issue Liquid Biopsy in Thoracic Cancer
Open Access
Review
Possible applications of salvianolic acid B against different cancers
Iram Shahzadi ... Reza Mohammadinejad
Published: August 31, 2020 Explor Target Antitumor Ther. 2020;1:218–238
This article belongs to the special issue Targeting Transcription Factors for Cancer Therapy
Open Access
Review
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors
Peiyi Zhang ... Guangrong Zheng
Published: August 31, 2020 Explor Target Antitumor Ther. 2020;1:259–272
This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)
Open Access
Commentary
Circulating cancer stem cells: an interesting niche to explore
Federica Papaccio
Published: August 31, 2020 Explor Target Antitumor Ther. 2020;1:253–258
This article belongs to the special issue Liquid Biopsy in Thoracic Cancer
Open Access
Review
Future directions and management of liquid biopsy in non-small cell lung cancer
Alessia Maria Cossu ... Marco Bocchetti
Published: August 31, 2020 Explor Target Antitumor Ther. 2020;1:239–252
This article belongs to the special issue Liquid Biopsy in Thoracic Cancer
Open Access
Review
A brief overview of antitumoral actions of bruceine D
Zi Wayne Sin ... Manoj Garg
Published: August 31, 2020 Explor Target Antitumor Ther. 2020;1:200–217
This article belongs to the special issue Targeting Transcription Factors for Cancer Therapy
Open Access
Review
Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors
Rachael Arthur ... Graham Packham
Published: June 29, 2020 Explor Target Antitumor Ther. 2020;1:131–152
This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)
Open Access
Review
Role of liquid biopsy for thoracic cancers immunotherapy
Raimondo Di Liello ... Paloma Martín-Martorell
Published: June 29, 2020 Explor Target Antitumor Ther. 2020;1:183–199
This article belongs to the special issue Liquid Biopsy in Thoracic Cancer
Open Access
Review
Integration of PARP-inhibitors in ovarian cancer therapy
Antonella Pietragalla ... Gennaro Daniele
Published: June 29, 2020 Explor Target Antitumor Ther. 2020;1:171–182
Open Access
Review
An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)
Irum Naz ... Kwang Seok Ahn
Published: June 29, 2020 Explor Target Antitumor Ther. 2020;1:153–170
This article belongs to the special issue Targeting Transcription Factors for Cancer Therapy
Open Access
Review
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
Giuliano Palumbo ... Alessandro Morabito
Published: April 28, 2020 Explor Target Antitumor Ther. 2020;1:117–130
Open Access
Case Report
Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis
Valeria Ferla ... Nicola Stefano Fracchiolla
Published: April 28, 2020 Explor Target Antitumor Ther. 2020;1:109–116
Open Access
Review
The impact of tumour pH on cancer progression: strategies for clinical intervention
Carol Ward ... Simon P Langdon
Published: April 28, 2020 Explor Target Antitumor Ther. 2020;1:71–100
Open Access
Original Article
Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients
Paola Castillo ... Cristina Teixido
Published: April 28, 2020 Explor Target Antitumor Ther. 2020;1:101–108
Open Access
Review
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma
Anna Maria Rachiglio ... Nicola Normanno
Published: February 29, 2020 Explor Target Antitumor Ther. 2020;1:53–70
Open Access
Review
Inhibitors of the Fanconi anaemia pathway as potential antitumour agents for ovarian cancer
Sarah J Taylor ... Simon P Langdon
Published: February 29, 2020 Explor Target Antitumor Ther. 2020;1:26–52
Open Access
Review
Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms
Joe Taylor ... Graham Packham
Published: February 29, 2020 Explor Target Antitumor Ther. 2020;1:3–25
Previous